ARCHIVES

Q & A With Shannon Brownlee: Task Force Independence at Stake In Debate over PSA Screening

This article is from The Cancer Letter archive.

Vol. 37 No. 37 | October 6, 2011

Download PDF Visit The Full Archive

Related Articles

Breast Cancer Strategic Plan Underway Following HHS Secretary’s Conference

January 7, 1994

Who Makes This Drug? Secretive Contract Manufacturing Agreements Complicate Solutions to Shortages of Generics

January 3, 2014

FDA Proposes “Clarification” Of Clinical Studies regulations, Including Sanctions, Inspections

August 18, 1978

NCI Director To Decide Fate Of P-4 After NCAB Meeting In June.

April 20, 2007

DCT Board Approves Concepts For Acoustic Microscopy, Taxol Development, AIDS R&D

June 15, 1990

NCI Developing Policy On Relations Between Industry, DCT Clinical Trials

July 29, 1983